Apixaban in Hemodialysis
NCT02672709
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
End-stage Renal Disease
Interventions
DRUG:
apixaban
Sponsor
Jewish General Hospital